Please assess the completion status of the following clinical trial:

Trial Title: Locally Delivered Atorvastatin & Rosuvastatin for Treatment of Furcation Defects in Chronic Periodontitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Systemically healthy patients with mandibular class II furcation defects and asymptomatic endodontically vital mandibular molars with radiolucency in furcation area with PD ≥ 5mm and horizontal PD ≥ 3mm and with no history of antibiotic or any periodontal therapy in past 6 months were included in the study~Exclusion Criteria:~* Subjects with any known systemic disease, allergic to statins, on systemic statin therapy, alcoholics, tobacco users, pregnant or lactating women

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- group 1 (Type: PLACEBO_COMPARATOR): Scaling and root planing (SRP) followed by placebo gel local drug delivery
- group 2 (Type: ACTIVE_COMPARATOR): SRP followed by 1.2% rosuvastatin (RSV) gel
- group 3 (Type: ACTIVE_COMPARATOR): SRP followed by 1.2% Atorvastatin (ATV) gel

Based on this trial design, predict the completion outcome and termination type (if applicable).